Tissue microarray analysis of EGFR and HER2 oncogene copy number alterations in squamous cell carcinoma of the larynx
- 8 December 2004
- journal article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 131 (3) , 199-203
Abstract
To evaluate EGFR and HER2 copy number changes and to assess their significance to tumor progression in a large group of patients with larynx cancer through the construction of a tissue microarray (TMA) consisting of 1,385 biopsies. Fluorescent in situ hybridization (FISH) was applied to analyze the tumors. FISH was successful for EGFR in 1,080 (77.98%) and for HER2 in 683 (49.31%). HER2 was amplified in 1.02% of cases. Amplification did not correlate with the tumor phenotype-clinical stage, and grade. The low frequency of amplification of HER2 oncogene in larynx tumors showed that the mechanism responsible for the high level of receptor overexpression still remains unclear in the majority of cases. Amplification of EGFR was found in 10.37% of cases. The analysis revealed a lack of correlation between amplification of the oncogenes and the tumor phenotype. We observed a lack of difference between the samples of primary tumors and advanced disease carcinomas—tumors with regional/distant metastases and recurrent tumors regarding oncogene amplification. These results suggest that EGFR amplification is a relatively rare event in larynx carcinogenesis that obviously does not predispose to tumor progression.Keywords
This publication has 35 references indexed in Scilit:
- High‐throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancerThe Journal of Pathology, 2003
- Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progressionGenes, Chromosomes and Cancer, 2002
- Epidermal growth factor receptor gene amplification is correlated with laminin-5 γ2 chain expression in oral squamous cell carcinoma cell linesCancer Letters, 2002
- Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughputin situ studiesThe Journal of Pathology, 2001
- New chromosomal regions with high-level amplifications in squamous cell carcinomas of the larynx and pharynx, identified by comparative genomic hybridizationThe Journal of Pathology, 2001
- Chromosomes 7,17 Polysomies and Overexpression of Epidermal Growth Factor Receptor and p53 Protein in Epithelial Hyperplastic Laryngeal LesionsOncology, 2000
- C-erbB-2 Immunostaining in Laryngeal CancerActa Oto-Laryngologica, 1999
- Amplification of ERBB oncogenes in squamous cell carcinomas of the head and neckEuropean Journal of Cancer, 1996
- Genetisches Screening von Kopf-Hals-Karzinomen mittels der Komparativen Genomischen Hybridisierung (CGH)Laryngo-Rhino-Otologie, 1996
- Analysis of gene amplification in head‐and‐neck squamous‐cell carcinomasInternational Journal of Cancer, 1991